Fasting Insulin
Females, Age 30-39
The median fasting insulin for US females aged 30-39 is 9.5 µU/mL (57 pmol/L), with 90% of the population falling between 3.5 µU/mL and 29.6 µU/mL.
NHANES 2017-March 2020 Pre-Pandemic 2017-2020 · Sample size: 322 participants · Unit: µU/mL
Percentile Distribution
Unit:
| Percentile | P5 | P10 | P25 | P50 | P75 | P90 | P95 |
|---|---|---|---|---|---|---|---|
| Value (µU/mL) | 3.5 | 4.2 | 5.6 | 9.5 | 16.9 | 25.2 | 29.6 |
| 95% CI | 2.4 | 3.5 | 5 | 8.3 | 13.5 | 23.5 | 27.2 |
| Percentile | Value (µU/mL) | 95% CI |
|---|---|---|
| P5 | 3.5 | 2.4 |
| P10 | 4.2 | 3.5 |
| P25 | 5.6 | 5 |
| P50 | 9.5 | 8.3 |
| P75 | 16.9 | 13.5 |
| P90 | 25.2 | 23.5 |
| P95 | 29.6 | 27.2 |
The 95% confidence interval (CI) is the range of values for the population percentile that are consistent with this sample, given how NHANES selected participants. It describes uncertainty in the percentile, not in any one person's result.
5.6 9.5 16.9
P25 P50 P75
P5 3.5 P95 29.6
Data and Methodology
- Dataset
- NHANES 2017-March 2020 Pre-Pandemic ( NHANES 2017-2020 2020 , Survey-weighted percentiles from fasting subsample)
- Survey years
- 2017-2020
- Measurement
- Measured by two-site immunoenzymometric assay on Tosoh AIA-900. How it was measured
- Sample size
- 322 participants
- Reference population
- US civilian non-institutionalized females aged 30-39 from NHANES 2017-March 2020. Includes the full population (not restricted to healthy individuals) to reflect the population distribution.
- Exclusion criteria
-
- Missing fasting insulin measurement (LBXIN)
- Missing or zero fasting sample weight (WTSAF)
- Age outside 30-39 range
- Notes
- Percentiles computed using the combined pre-pandemic fasting-subsample weight (WTSAFPRP). Fasting insulin measured as LBXIN in µU/mL from the fasting subsample. Corrected October 2026: the previous version of these figures counted 345 participants in this group, including 23 who did not meet the fasting requirement of 8 to under 24 hours.